120 related articles for article (PubMed ID: 15119047)
21. Anti-IgE therapy combined with SIT: contra.
Larché M
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 2003; (94):272-6; discussion 276-8. PubMed ID: 15119048
[No Abstract] [Full Text] [Related]
22. Long-term effects of conventional immunotherapy in southern California.
Nagaya H
Ann Allergy; 1980 Apr; 44(4):193-9. PubMed ID: 6154434
[TBL] [Abstract][Full Text] [Related]
23. The long and short of allergy shots.
Wong J
Health News; 1999 Sep; 5(11):3. PubMed ID: 10513253
[No Abstract] [Full Text] [Related]
24. [Case of pollinosis to grass pollens who presented with dyspnea successfully treated by rush immunotherapy].
Kawada Y; Takamasu T; Inuo C; Aikawa H; Kurihara K
Arerugi; 2007 Nov; 56(11):1403-7. PubMed ID: 18059155
[TBL] [Abstract][Full Text] [Related]
25. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response.
Rondón C; Doña I; López S; Campo P; Romero JJ; Torres MJ; Mayorga C; Blanca M
Allergy; 2008 Oct; 63(10):1352-8. PubMed ID: 18782115
[TBL] [Abstract][Full Text] [Related]
26. Additional benefit of a third year of specific grass pollen allergoid immunotherapy in patients with seasonal allergic rhinitis.
Williams A; Henzgen M; Rajakulasingam K
Eur Ann Allergy Clin Immunol; 2007 Apr; 39(4):123-6. PubMed ID: 17523386
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a hypoallergenic recombinant Bet v 1 variant as a candidate for allergen-specific immunotherapy.
Kahlert H; Suck R; Weber B; Nandy A; Wald M; Keller W; Cromwell O; Fiebig H
Int Arch Allergy Immunol; 2008; 145(3):193-206. PubMed ID: 17912007
[TBL] [Abstract][Full Text] [Related]
28. Allergen-specific immunotherapy with recombinant grass pollen allergens.
Jutel M; Jaeger L; Suck R; Meyer H; Fiebig H; Cromwell O
J Allergy Clin Immunol; 2005 Sep; 116(3):608-13. PubMed ID: 16159631
[TBL] [Abstract][Full Text] [Related]
29. Grass pollen immunotherapy for treatment of allergic rhinitis.
Slovick A; Durham SR; Till SJ
BMJ; 2014 Nov; 349():g6586. PubMed ID: 25403477
[No Abstract] [Full Text] [Related]
30. Anti-IgE antibodies for the treatment of IgE-mediated allergic diseases.
Chang TW; Wu PC; Hsu CL; Hung AF
Adv Immunol; 2007; 93():63-119. PubMed ID: 17383539
[TBL] [Abstract][Full Text] [Related]
31. Specific IgE serum concentration is associated with symptom severity in children with seasonal allergic rhinitis.
Rolinck-Werninghaus C; Keil T; Kopp M; Zielen S; Schauer U; von Berg A; Wahn U; Hamelmann E;
Allergy; 2008 Oct; 63(10):1339-44. PubMed ID: 18782113
[TBL] [Abstract][Full Text] [Related]
32. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Durham SR; Yang WH; Pedersen MR; Johansen N; Rak S
J Allergy Clin Immunol; 2006 Apr; 117(4):802-9. PubMed ID: 16630937
[TBL] [Abstract][Full Text] [Related]
33. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy.
Didier A; Melac M; Montagut A; Lhéritier-Barrand M; Tabar A; Worm M
Allergy; 2009 Jan; 64(1):166-71. PubMed ID: 19076546
[TBL] [Abstract][Full Text] [Related]
34. Allergenicity and cross-reactivity of pine pollen.
Gastaminza G; Lombardero M; Bernaola G; Antepara I; Muñoz D; Gamboa PM; Audicana MT; Marcos C; Ansotegui IJ
Clin Exp Allergy; 2009 Sep; 39(9):1438-46. PubMed ID: 19573163
[TBL] [Abstract][Full Text] [Related]
35. IL-9 and c-Kit+ mast cells in allergic rhinitis during seasonal allergen exposure: effect of immunotherapy.
Nouri-Aria KT; Pilette C; Jacobson MR; Watanabe H; Durham SR
J Allergy Clin Immunol; 2005 Jul; 116(1):73-9. PubMed ID: 15990777
[TBL] [Abstract][Full Text] [Related]
36. The importance of quantifying skin reactivity in treating allergic rhinitis with immunotherapy.
Trevino RJ; Veling MC
Ear Nose Throat J; 2000 May; 79(5):362-4, 366. PubMed ID: 10832201
[TBL] [Abstract][Full Text] [Related]
37. Bahia grass pollen specific IgE is common in seasonal rhinitis patients but has limited cross-reactivity with Ryegrass.
Davies JM; Bright ML; Rolland JM; O'hehir RE
Allergy; 2005 Feb; 60(2):251-5. PubMed ID: 15647049
[TBL] [Abstract][Full Text] [Related]
38. [Interest of allergology evaluation for the treatment of asthma and rhinosinusitis].
Michel O
Rev Med Brux; 2008 Sep; 29(4):393-9. PubMed ID: 18949994
[TBL] [Abstract][Full Text] [Related]
39. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
[TBL] [Abstract][Full Text] [Related]
40. Diminished response to grass pollen allergen challenge in subjects with concurrent house dust mite allergy.
Reinartz SM; van Ree R; Versteeg SA; Zuidmeer L; van Drunen CM; Fokkens WJ
Rhinology; 2009 Jun; 47(2):192-8. PubMed ID: 19593978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
